-
公开(公告)号:US20230279350A1
公开(公告)日:2023-09-07
申请号:US18016972
申请日:2021-07-30
申请人: CELLECTIS S.A.
IPC分类号: C12N5/0783 , C07K16/28 , A61P35/00
CPC分类号: C12N5/0636 , C07K16/2887 , C07K16/2896 , A61P35/00 , C07K2317/53 , C07K2317/565 , C07K2319/03
摘要: The present invention concerns new engineered immune cells expressing two CARs directed against two different targets, polynucleotides for preparing said immune cells, pharmaceutical compositions comprising said immune cells, and the use of said immune cells in the treatment of cancers.